Skip to main content
Premium Trial:

Request an Annual Quote

Waters' Q1 Revenues Rise 14 Percent on 'Broad-Based' Growth

NEW YORK (GenomeWeb News) — Waters today said first-quarter revenue increased 14 percent and net income jumped 26 percent.
Total revenue for the three months ended March 31 rose to $330.8 million from $290 million year over year.
CEO Doug Berthiaume said the “strong start for 2007” represents continued growth from 2006, and said the “broad-based” growth was “indicative of a very positive response to our newly introduced instrument systems and consumable products.”
R&D spending dipped to $18.7 million from $19 million in the prior-year period.
Net income grew to $55.9 million from $44.2 million year over year.
As of March 31, Waters had $503.7 million in cash and cash equivalents.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.